[1]
Fang, J., Genco, M. and Caskey, R. 2020. COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use. European Journal of Case Reports in Internal Medicine. 7, 11 (Oct. 2020). DOI:https://doi.org/10.12890/2020_001943.